TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Secured Loans History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Secured Loans | ₹11,651 Cr | ₹1,192 Cr | ₹1,604 Cr | ₹2,496 Cr | ₹2,123 Cr |
What is the latest Secured Loans ratio of TORRENT PHARMACEUTICALS ?
| Year | Secured Loans |
|---|---|
| Mar2026 | ₹11,651 Cr |
| Mar2025 | ₹1,192 Cr |
| Mar2024 | ₹1,604 Cr |
| Mar2023 | ₹2,496 Cr |
| Mar2022 | ₹2,123 Cr |
How is Secured Loans of TORRENT PHARMACEUTICALS Trending?
| Years | Secured Loans | % Change | |
|---|---|---|---|
| Mar2026 | ₹11,651 Cr | 877.65 | |
| Mar2025 | ₹1,192 Cr | -25.69 | |
| Mar2024 | ₹1,604 Cr | -35.75 | |
| Mar2023 | ₹2,496 Cr | 17.57 | |
| Mar2022 | ₹2,123 Cr | - | |
Compare Secured Loans of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹188,670.8 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| MANKIND PHARMA | ₹103,472.0 Cr | -2.4% | 1.2% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -0.9% |
10.1% |
44.6% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses